Oncotarget is a peer-reviewed multidisciplinary journal that was launched in 2010 by scientists working in cancer research and other areas of oncology biology. It is an open access journal to help in the dissemination of oncology research results to large numbers of people and researchers around the world. Oncotarget aims at making scientific research on cancer widely available. However, the journal also publishes a lot of findings other topics such as aging, immunology, microbiology, and pathology. Download output styles at Endnote.com.
Cancer has become a serious public health concern, and it is encouraging that Oncotarget has focused its energies on making oncology findings available to those involved in the frontline war against this stubborn disease. Oncotarget makes bi-weekly publications to ensure that there is a constant flow of information. This is how it contributes to scientific progress in oncology; by publishing work of some of the leading lights in the field. The journal intends to make scientific evidence easy to share. Oncotarget brings together various experts in multiple oncology fields to expand the number of topics covered in the journal. Watch this video on Youtube.
The journal has had an enormous impact since inception. It has a broad reach of about ten thousand cities to date. This has turned it into one of the most reliable and accessible medical journals for oncology. It has been indexed by Biosis previews, Scopus and Index Medicus. It is an excellent success and can be credited to high editorial standards set by the editors. Oncotarget has some of the most distinguished scientists and researchers for editors including notable Nobel prize winners.
Oncotarget also promotes the application of its research to future scientific inquiry. That is why it sponsors medical conferences around the world. The Gordon research conference recently held in Italy is one example. That discussed everything ranging from stem cell aging, progression to cancer initiation. At the Frontiers in Cancer Science Conference, Oncotarget proudly sponsored the work of several scientists working on cutting edge treatments for cancer. Multiple scholars received accolades and distinguished honors for their work in the field of oncology. By creating an environment for scientific exchange Oncotarget has furthered the way that oncology is discussed and research is propagated.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/